These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8524418)

  • 1. ['Office' or 'white-coat hypertension'].
    Janssen MC; Thien T
    Ned Tijdschr Geneeskd; 1995 Nov; 139(47):2401-4. PubMed ID: 8524418
    [No Abstract]   [Full Text] [Related]  

  • 2. White coat effect in treated hypertensive patients: sex differences.
    Myers MG; Reeves RA
    J Hum Hypertens; 1995 Sep; 9(9):729-33. PubMed ID: 8551486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implications of white coat hypertension.
    Carek PJ; Carson DS; Cooke CE; Weart CW
    Am Fam Physician; 1995 Jul; 52(1):163-8. PubMed ID: 7604760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do we need out-of-office blood pressure in every patient?
    Parati G; Valentini M
    Curr Opin Cardiol; 2007 Jul; 22(4):321-8. PubMed ID: 17556885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Level of blood pressure control in a hypertensive population when measurements are performed outside the clinical setting.
    Félix-Redondo FJ; Fernández-Bergés D; Espinosa-Garcia J; Pozuelos-Estrada J; Molina-Martínez LM; Pérez-Castán JF; Ríos-Rivera J; Valiente-Rubio JI; Gómez-de-la-Cámara A; Rodríguez-Pascual N
    Cardiol J; 2009; 16(1):57-67. PubMed ID: 19130417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of strategy for the detection of white coat hypertension based on ambulatory and home blood pressure monitoring.
    Stergiou GS; Alamara CV; Skeva II; Mountokalakis TD
    J Hum Hypertens; 2004 Feb; 18(2):85-9. PubMed ID: 14730322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. White-coat hypertension in adults and children.
    Verdecchia P
    Blood Press Monit; 1999; 4(3-4):175-9. PubMed ID: 10490871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of resistant hypertension determined by self-measured blood pressure at home and office blood pressure measurements: the J-HOME study.
    Oikawa T; Obara T; Ohkubo T; Kikuya M; Asayama K; Metoki H; Komai R; Murai K; Hashimoto J; Totsune K; Imai Y;
    J Hypertens; 2006 Sep; 24(9):1737-43. PubMed ID: 16915022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors for the white coat effect in general practice patients with suspected and treated hypertension.
    Lindbaek M; Sandvik E; Liodden K; Mjell J; Ravnsborg-Gjertsen K
    Br J Gen Pract; 2003 Oct; 53(495):790-3. PubMed ID: 14601355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of the white-coat effect in hypertensive subjects.
    Mansoor GA; McCabe EJ; White WB
    J Hum Hypertens; 1996 Feb; 10(2):87-92. PubMed ID: 8867561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White coat hypertension in adolescents.
    Koch VH; Furusawa EA; Saito MI; Colli A; Ignes EC; Okay Y; Mion Júnior D
    Clin Nephrol; 1999 Nov; 52(5):297-303. PubMed ID: 10584993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ambulatory blood pressure monitoring to study white coat syndrome in patients with hypertension seen in primary care].
    Villalba Alcalá F; Lapetra Peralta J; Mayoral Sánchez E; Espino Montoro A; Cayuela Domínguez A; López Chozas JM
    Rev Esp Cardiol; 2004 Jul; 57(7):652-60. PubMed ID: 15274850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ["White coat" hypertension].
    Gadzhiev AN
    Klin Med (Mosk); 2004; 82(2):15-9. PubMed ID: 15106504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Masked hypertension and white-coat hypertension: therapeutic navigation between scylla and charybdis.
    Messerli FH; Cotiga D
    J Am Coll Cardiol; 2005 Aug; 46(3):516-7. PubMed ID: 16053967
    [No Abstract]   [Full Text] [Related]  

  • 15. White coat hypertension: to treat or not to treat?
    Pickering TG
    Am Fam Physician; 1995 Jul; 52(1):48, 58. PubMed ID: 7604771
    [No Abstract]   [Full Text] [Related]  

  • 16. Is ambulatory blood pressure monitoring cost-effective in the routine surveillance of treated hypertensive patients in primary care?
    Lorgelly P; Siatis I; Brooks A; Slinn B; Millar-Craig MW; Donnelly R; Manning G
    Br J Gen Pract; 2003 Oct; 53(495):794-6. PubMed ID: 14601356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association between body-mass index and white-coat hypertension among referred patients.
    Ben-Dov IZ; Mekler J; Ben-Arie L; Bursztyn M
    Blood Press Monit; 2007 Apr; 12(2):95-9. PubMed ID: 17353652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Office blood pressure and 24-hour ambulatory blood pressure measurements: high proportion of disagreement in resistant hypertension.
    Rodrigues CS; Bloch KV; da Rocha Nogueira A
    J Clin Epidemiol; 2009 Jul; 62(7):745-51. PubMed ID: 19128937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Masked hypertension assessed by ambulatory blood pressure versus home blood pressure monitoring: is it the same phenomenon?
    Stergiou GS; Salgami EV; Tzamouranis DG; Roussias LG
    Am J Hypertens; 2005 Jun; 18(6):772-8. PubMed ID: 15925734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [White coat hypertension: high blood pressure in physician's office, but normal otherwise].
    Enström I
    Lakartidningen; 2004 Nov; 101(45):3532-3. PubMed ID: 15575428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.